Metabolic syndrome and gastrointestinal diseases - PubMed (original) (raw)

Review

Metabolic syndrome and gastrointestinal diseases

Sumio Watanabe et al. J Gastroenterol. 2007 Apr.

Abstract

Metabolic syndrome is a cluster of metabolic abnormalities consisting essentially of obesity, especially abdominal obesity. Metabolic syndrome has been highlighted as a risk factor for cardiovascular and other chronic diseases. Obesity has been implicated in various gastrointestinal diseases such as gastroesophageal reflux diseases and colorectal cancer. Recently, abdominal obesity has been shown to be more important than obesity as expressed by an elevated body mass index as a causative factor for the development of these diseases. In addition to the mechanical effects of obesity, such as an increase in intra-abdominal pressure from large amounts of adipose tissue, substances that adipose tissues secrete, such as tumor necrosis factor-alpha, interleukin-6, leptin, and insulin-like growth factor-1, have been proposed to be pathogenic links to these diseases. In this review, we discuss the association of metabolic syndrome or the individual components of metabolic syndrome, focusing on obesity and abdominal obesity, with gastrointestinal diseases.

PubMed Disclaimer

Similar articles

• Adiposity and columnar-lined esophagus.
  Lenglinger J, Eisler M, Riegler FM. Lenglinger J, et al. Am J Gastroenterol. 2008 May;103(5):1316-7. doi: 10.1111/j.1572-0241.2007.01782_9.x. Am J Gastroenterol. 2008. PMID: 18477363 No abstract available.
• Influence of metabolic syndrome on upper gastrointestinal disease.
  Sogabe M, Okahisa T, Kimura T, Okamoto K, Miyamoto H, Muguruma N, Takayama T. Sogabe M, et al. Clin J Gastroenterol. 2016 Aug;9(4):191-202. doi: 10.1007/s12328-016-0668-1. Epub 2016 Jul 2. Clin J Gastroenterol. 2016. PMID: 27372302 Review.
• Visceral obesity and the risk of Barrett's esophagus.
  Akiyama T, Yoneda M, Maeda S, Nakajima A, Koyama S, Inamori M. Akiyama T, et al. Digestion. 2011;83(3):142-5. doi: 10.1159/000321810. Epub 2011 Jan 21. Digestion. 2011. PMID: 21266807 Review.
• Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma.
  Veugelers PJ, Porter GA, Guernsey DL, Casson AG. Veugelers PJ, et al. Dis Esophagus. 2006;19(5):321-8. doi: 10.1111/j.1442-2050.2006.00602.x. Dis Esophagus. 2006. PMID: 16984526
• Role of obesity in Barrett's esophagus and cancer.
  Murray L, Romero Y. Murray L, et al. Surg Oncol Clin N Am. 2009 Jul;18(3):439-52. doi: 10.1016/j.soc.2009.03.010. Surg Oncol Clin N Am. 2009. PMID: 19500735 Review.

Cited by

• Obesity and Risk of Peptic Ulcer Disease: A Large-Scale Health Check-Up Cohort Study.
  Pyo JH, Lee H, Kim JE, Choi YH, Kim TJ, Min YW, Min BH, Lee JH, Rhee PL, Yoo H, Kim K, Kim JJ. Pyo JH, et al. Nutrients. 2019 Jun 6;11(6):1288. doi: 10.3390/nu11061288. Nutrients. 2019. PMID: 31174419 Free PMC article.
• Effects of the body mass index (BMI) on the surgical outcomes of laparoscopic fundoplication for gastro-esophageal reflux disease: a propensity score-matched analysis.
  Hoshino M, Omura N, Yano F, Tsuboi K, Yamamoto SR, Akimoto S, Masuda T, Kashiwagi H, Yanaga K. Hoshino M, et al. Surg Today. 2018 Feb;48(2):236-241. doi: 10.1007/s00595-017-1579-6. Epub 2017 Aug 7. Surg Today. 2018. PMID: 28785908
• Sex differences in associations among metabolic syndrome, obesity, related biomarkers, and colorectal adenomatous polyp risk in a Japanese population.
  Nakai K, Watari J, Tozawa K, Tamura A, Hara K, Yamasaki T, Kondo T, Kono T, Tomita T, Ohda Y, Oshima T, Fukui H, Sakurai J, Kim Y, Hayakawa Y, Fujisawa T, Morimoto T, Miwa H. Nakai K, et al. J Clin Biochem Nutr. 2018 Sep;63(2):154-163. doi: 10.3164/jcbn.18-11. Epub 2018 Apr 3. J Clin Biochem Nutr. 2018. PMID: 30279628 Free PMC article.
• Abdominal obesity as a risk factor for the development of erosive esophagitis in subjects with a normal esophago-gastric junction.
  Koo JS, Lee SW, Park SM, Jung SW, Yim HJ, Park JJ, Chun HJ, Lee HS, Choi JH, Kim CD, Ryu HS. Koo JS, et al. Gut Liver. 2009 Dec;3(4):276-84. doi: 10.5009/gnl.2009.3.4.276. Epub 2009 Dec 31. Gut Liver. 2009. PMID: 20431761 Free PMC article.
• A Mouse Model of Metabolic Syndrome; Increase in Visceral Adipose Tissue Precedes the Development of Fatty Liver and Insulin Resistance in High-Fat Diet-Fed Male KK/Ta Mice.
  Akagiri S, Naito Y, Ichikawa H, Mizushima K, Takagi T, Handa O, Kokura S, Yoshikawa T. Akagiri S, et al. J Clin Biochem Nutr. 2008 Mar;42(2):150-7. doi: 10.3164/jcbn.2008022. J Clin Biochem Nutr. 2008. PMID: 18385833 Free PMC article.

References

1. 1. Ann Intern Med. 1999 Jun 1;130(11):883-90 - PubMed
2. 1. Neurogastroenterol Motil. 2006 Nov;18(11):987-94 - PubMed
3. 1. Gastrointest Endosc. 2003 Sep;58(3):350-5 - PubMed
4. 1. Aliment Pharmacol Ther. 2005 Nov 15;22(10):1005-10 - PubMed
5. 1. Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):133-7 - PubMed

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information